ebook img

Adjuvant Therapy for Breast Cancer PDF

483 Pages·2009·5.832 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Adjuvant Therapy for Breast Cancer

A Cancer Treatment and Research d j u Steven T. Rosen, M.D., Series Editor v a Robert H. Lurie Comprehensive Cancer Center n Northwestern University Medical School t T h e r a p y f Adjuvant Therapy o r B r e for Breast Cancer a s t C a n c e r edited by C Monica Castiglione a s t ig Martine J. Piccart l i o n e • P i c c a r t 1 23 1 Adjuvant Therapy for Breast Cancer Cancer Treatment and Research Steven T.Rosen, MD, Series Editor Leong,S.P.L.(ed.):AtlasofSelectiveSentinelLymphadenectomyforMelanoma,BreastCancerand ColonCancer.2002.ISBN1-4020-7013-6. Andersson,B.,MurrayD.(eds.):ClinicallyRelevantResistanceinCancerChemotherapy.2002.ISBN 1-4020-7200-7. Beam,C.(ed.):BiostatisticalApplicationsinCancerResearch.2002.ISBN1-4020-7226-0. Brockstein,B.,Masters,G.(eds.):HeadandNeckCancer.2003.ISBN1-4020-7336-4. Frank,D.A.(ed.):SignalTransductioninCancer.2003.ISBN1-4020-7340-2. Figlin,R.A.(ed.):KidneyCancer.2003.ISBN1-4020-7457-3. Kirsch,M.,Black,P.McL.(eds.):AngiogenesisinBrainTumors.2003.ISBN1-4020-7704-1. Keller,E.T.,Chung,L.W.K.(eds.):TheBiologyofSkeletalMetastases.2004. ISBN1-4020-7749-1. Kumar,R.(ed.):MolecularTargetingandSignalTransduction.2004.ISBN1-4020-7822-6. Verweij,J.,Pinedo,H.M.(eds.):TargetingTreatmentofSoftTissueSarcomas.2004. ISBN1-4020-7808-0. Finn,W.G.,Peterson,L.C.(eds.):HematopathologyinOncology.2004.ISBN1-4020-7919-2. Farid,N.(ed.):MolecularBasisofThyroidCancer.2004.ISBN1-4020-8106-5. Khleif,S.(ed.):TumorImmunologyandCancerVaccines.2004.ISBN1-4020-8119-7. Balducci,L.,Extermann,M.(eds.):BiologicalBasisofGeriatricOncology.2004.ISBN Abrey,L.E.,Chamberlain,M.C.,Engelhard,H.H.(eds.):LeptomeningealMetastases.2005. ISBN0-387-24198-1. Platanias,L.C.(ed.):CytokinesandCancer.2005.ISBN0-387-24360-7. Leong,S.P.L.,Kitagawa,Y.,Kitajima,M.(eds.):SelectiveSentinelLymphadenectomyforHuman SolidCancer.2005.ISBN0-387-23603-1. Small,W.,Jr.,Woloschak,G.(eds.):RadiationToxicity:APracticalGuide.2005. ISBN1-4020-8053-0. Haefner,B.,Dalgleish,A.(eds.):TheLinkBetweenInflammationandCancer.2006. ISBN0-387-26282-2. Leonard,J.P.,Coleman,M.(eds.):Hodgkin’sandNon-Hodgkin’sLymphoma.2006. ISBN0-387-29345. Leong,S.P.L.(ed.):CancerClinicalTrials:ProactiveStrategies.2006.ISBN0-387-33224-3. Meyers,C.(ed.):Aids-AssociatedViralOncogenesis.2007.ISBN978-0-387-46804-4. Ceelen,W.P.(ed.):PeritonealCarcinomatosis:AMultidisciplinaryApproach.2007. ISBN978-0-387-48991-9. Leong,S.P.L.(ed.):CancerMetastasisandtheLymphovascularSystem:BasisforRationalTherapy. 2007.ISBN978-0-387-69218-0. Raizer,J.,Abrey,L.E.(eds.):BrainMetastases.2007.ISBN978-0-387-69221-0. Woodruff,T.,Snyder,K.A.(eds.):Oncofertility.2007.ISBN978-0-387-72292-4. Angelos,P.(ed.):EthicalIssuesinCancerPatientCare,SecondEdition.2008. ISBN978-0-387-73638-9. Ansell,S.(ed.):RareHematologicalMalignancies.2008.ISBN978-0-387-73743-0. Gradishar,W.J.,Wood,W.C.(eds.):AdvancesinBreastCareManagement,SecondEdition.2008. 978-0-387-73160-5. Blake,M.,Kalra,M.(eds.):ImaginginOncology.2008.ISBN978-0-387-75586-1. Bishop,M.R.(ed.):HematopoieticStemCellTransplantation.2008.ISBN978-0-387-78579-0. Stockfleth,E.,Ulrich,C.(eds.):SkinCancerafterOrganTransplantation.2008. ISBN978-0-387-78573-8. Fuqua,S.A.W.(ed.):HormoneReceptorsinBreastCancer.2008.ISBN:978-0-387-09462-5. Green,D.,Kwaan,H.C.(eds.):CoagulationinCancer.2009.ISBN:978-0-387-79961-2. Stack,M.S.,Fishman,D.A.(eds.):OvarianCancer,SecondEdition.2009. ISBN:978-0-387-98093-5. Goldman,S.,Turner,C.D.(eds):LateEffectsofTreatmentforBrainTumors,2009. ISBN:978-0-387-77102-1. Castiglione,M.,Piccart,M.(eds):AdjuvantTherapyforBreastCancer,2009. ISBN:978-0-387-75114-6. Adjuvant Therapy for Breast Cancer Edited by Monica Castiglione, M.D., M.H.A University of Geneva Geneva, Switzerland And Martine J. Piccart, M.D., Ph.D. Jules Bordet Institute Brussels, Belgium 1 3 Editors MonicaCastiglione MartineJ.Piccart UniversityofGeneva UniversiteLibreBruxelles ISPM/RGT Inst.JulesBordet BoulevarddelaCluse55 1000Bruxelles 1205Geneva Belgium Switzerland [email protected] [email protected] SeriesEditor: StevenT.Rosen,M.D. RobertH.LurieComprehensiveCancer Center NorthwesternUniversity Chicago,IL USA ISSN0927-3042 ISBN978-0-387-75114-6 e-ISBN978-0-387-75115-3 DOI10.1007/978-0-387-75115-3 SpringerDordrechtHeidelbergLondonNewYork LibraryofCongressControlNumber:2009921197 #SpringerScienceþBusinessMedia,LLC2009 Allrightsreserved.Thisworkmaynotbetranslatedorcopiedinwholeorinpartwithoutthewritten permissionofthepublisher(SpringerScienceþBusinessMedia,LLC,233SpringStreet,NewYork, NY10013,USA),exceptforbriefexcerptsinconnectionwithreviewsorscholarlyanalysis.Usein connectionwithanyformofinformationstorageandretrieval,electronicadaptation,computer software,orbysimilarordissimilarmethodologynowknownorhereafterdevelopedisforbidden. Theuseinthispublicationoftradenames,trademarks,servicemarks,andsimilarterms,evenifthey arenotidentifiedassuch,isnottobetakenasanexpressionofopinionastowhetherornottheyare subjecttoproprietaryrights. Whiletheadviceandinformationinthisbookarebelievedtobetrueandaccurateatthedateof going to press, neither the authors nor the editors nor the publisher can accept any legal responsibilityforanyerrorsoromissionsthatmaybemade.Thepublishermakesnowarranty, expressorimplied,withrespecttothematerialcontainedherein. Printedonacid-freepaper SpringerispartofSpringerScience+BusinessMedia(www.springer.com) Acknowledgments Wewouldliketothankallcontributorsfortheirenthusiasm WewouldliketothankLauraWalsh–whoalwaysbelievedintheproject– for her patience (a typical feminine characteristic!) and for her continuous support. WewouldliketothanktheteamatSpringerforeditorialwork v Contents PartI Basics HistoryofAdjuvantTherapy................................... 3 PinucciaValagussa PrognosticandPredictiveFactors............................... 13 LauraBiganzoli NewPerspectivesforTherapyChoice ............................ 31 Anne-CatherineAndres PathologyRoleinAdjuvantSetting.............................. 41 AngelikaReiner-Concin Guidelines,ConsensusConferencesandOverviews(Meta-analysis) ..... 63 KathleenI.Pritchard StatisticalIssuesandChallenges................................ 77 MeredithM.Regan PartII Treatments MultidisciplinaryCare:OptimisingTeamPerformance .............. 93 FrancesM.Boyle PreoperativeChemo-andEndocrineTherapy ...................... 103 RosalbaTorrisi AdjuvantChemotherapy ...................................... 121 M.Tubiana-HulinandM.Gardner PostoperativeEndocrineTherapyforInvasiveBreastCancer .......... 139 LeishaA.EmensandNancyE.Davidson vii viii Contents AdjuvantTherapyofBreastCancer–Bisphosphonates............... 163 TiinaSaarto PartIII NewWindintheAdjuvantSetting Trastuzumab ............................................... 181 EdithA.Perez,FrancesM.Palmieri,andShellyM.Brock Lapatinib:NewDirectionsinHER2DirectedTherapyforEarly StageBreastCancer ......................................... 197 A. JoChienandHopeS.Rugo PartIV SpecialIssues SupportiveCareDuringAdjuvantTreatment ...................... 219 AnnabelPollard Dosein(Adjuvant)ChemotherapyofBreastCancer ................. 239 Ulrike.Nitz TimingofAdjuvantTherapy ................................... 255 O.Pagani SequencingofSystemicTreatmentandRadiotherapy................ 281 PiaUrsulaHuguenin PartV SpecialPopulations YoungPatientswithBreastCancer.............................. 291 P.A.Francis SpecialPopulations:ElderlyPatients ............................ 299 DianaCrivellariandLuciaFratino AdjuvantTherapyinPatientswithBreastCancerDuringPregnancy ..... 317 SibylleLoibl PartVI AfterBreastCancerandTreatment,SequelaeofAdjuvant TreatmentSocialIssues InvestigationsAfterAdjuvantTherapy ........................... 331 SilviaDellapasqua QualityofLifeIssuesDuringAdjuvantEndocrineTherapy............ 353 LesleyFallowfieldandValerieJenkins Contents ix Fertility ................................................... 367 K.J.RuddyandA.H.Partridge CognitiveFunctioninBreastCancerSurvivors ..................... 387 JanetteVardy CostsofAdjuvantBreastCancerTreatments ...................... 421 NinaOestreicher SocialIssues:MaritalSupport.................................. 441 LouisePicard TheViewandRoleofBreastCancerAdvocacy..................... 451 StellaKyriakydes TheVoiceofaSpecialPatient.................................. 461 StefanAebi Finalword ................................................. 467 Index..................................................... 469 Contributors StefanAebi,MD BreastandGynecologicalCancerCenter,Departments ofMedicalOncologyandGynecology,UniversityHospital,Inselspital,Berne, Switzerland,[email protected] Anne-CatherineAndres,PhD DepartmentofClinicalResearch,University ofBern,Bern,Switzerland,[email protected] LauraBiganzoli,MD ‘‘SandroPitigliani’’MedicalOncologyUnit,Hospital ofPrato-IstitutoToscanoTumori,Prato,Italy,[email protected] FrancesM.Boyle,MBBS,PhD,FRACP PamMcLeanCentre,University ofSydney,Sydney,Australia,[email protected] ShellyM.Brock,MSN,ARNP-C DivisionofHematology/Oncologyand BreastClinic,MayoClinic,Jacksonville,Florida,USA MonicaCastiglione,MD,MHA UniversityofGeneva,ISPM/RGT,Boulevard delaCluse55,1205Geneva,Switzerland,[email protected] AmyJoChien,MD UniversityofCaliforniaSanFrancisco,HelenDiller Family Comprehensive Cancer Center, San Francisco, California, USA, [email protected] DianaCrivellari,MD DivisionofMedicalOncologyC,CentrodiRiferimento Oncologico,Aviano(PN),Italy,[email protected] NancyE.Davidson,MD UniversityofPittsburghCancerInstitute,University ofPittsburghSchoolofMedicine,Pittsburgh,Pennsylvania,USA, [email protected] SilviaDellapasqua,MD MedicalSenologyResearchUnit,DivisionofMedical Oncology,EuropeanInstituteofOncology,Milan,Italy,[email protected] LeishaA.Emens,MD,PhD DepartmentofOncology,TheJohnsHopkins University,Baltimore,Maryland,USA,[email protected] LesleyFallowfield,BSc,D.Phil BrightonandSussexMedicalSchool, UniversityofSussex,EastSussex,UK,[email protected] xi

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.